I added “interferon beta 1a-PEGylated” to the phase 3 list. Biogen did a phase 1 already and is going straight to phase 3, I assume because interferon has already been studied to death, and there are even pegylated versions of other interferons on the market (not for MS). The final bonus is that the phase 3 trial will only be for 1 year, not the usual 2 years (again, I assume because of the level of study that has already gone into similar substances). The trial is expected to start mid-year.
Interferon beta 1a-PEGylated